SCHEMBL17090568

SCHEMBL17090568

CC(CC(=O)OCI)C1CCC2C3CCC4CC(O)CCC4(C)C3CC(O)C12C

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 2/20 0.69
▸ MEN1 O00255 2/20 0.69
▸ KMT2A Q03164 2/20 0.69
▸ USP2 O75604 2/20 0.69
▸ MAPK1 P28482 2/20 0.69
▸ LMNA P02545 1/20 0.69
▸ GPBAR1 Q8TDU6 7/20 0.67
▸ SLC10A2 Q12908 2/20 0.67
▸ NR1H4 Q96RI1 2/20 0.67
▸ TBXA2R P21731 1/20 0.67
▸ PDE3A Q14432 1/20 0.67
▸ CA1 P00915 6/20 0.57
▸ CA2 P00918 6/20 0.57
▸ ABCC4 O15439 1/20 0.57
▸ CYP2C9 P11712 1/20 0.53
▸ HIF1A Q16665 1/20 0.53
▸ VDR P11473 1/20 0.53
▸ CYP3A4 P08684 2/20 0.51
▸ SLCO1B3 Q9NPD5 1/20 0.51
▸ SLCO1B1 Q9Y6L6 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12362226 0.91 MAPT (0.81) MAPTMEN1KMT2AUSP2MAPK1
SCHEMBL1014063 0.91 MAPT (0.81) MAPTMEN1KMT2AUSP2MAPK1
SCHEMBL10014096 0.87 MAPT (0.64) MAPTMEN1KMT2AUSP2MAPK1
SCHEMBL11646243 0.86 MAPT (0.66) MAPTMEN1KMT2AUSP2MAPK1
SCHEMBL1656466 0.86 GPBAR1 (0.81) MAPTMEN1KMT2AUSP2MAPK1
SCHEMBL15145513 0.86 GPBAR1 (0.81) MAPTMEN1KMT2AUSP2MAPK1
SCHEMBL20008826 0.84 MAPT (0.73) MAPTMEN1KMT2AUSP2MAPK1
SCHEMBL13570166 0.84 GPBAR1 (0.74) MAPTMEN1KMT2AUSP2MAPK1
SCHEMBL20008800 0.84 GPBAR1 (0.74) MAPTMEN1KMT2AUSP2MAPK1
SCHEMBL16226768 0.84 GPBAR1 (0.74) MAPTMEN1KMT2AUSP2MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9138442-B2 Compositions and methods for treating viral infections SPRING BANK PHARMACEUTICALS, INC. (US) 2015-09-22 — — US disclosed
Send feedback